William F. Metzger, Psc Optometrist Medicare: Medicare Enrolled Practice Location: 35 Augusta Ave, Ft Wright, KY 41011 Phone: 859-750-5642 Fax: 859-331-1742 |
Metzger Optometry Ky Pllc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 35 Augusta Ave, Ft Wright, KY 41011 Phone: 855-259-9183 |
Dr. William Ferdinand Metzger, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 35 Augusta Ave, Ft Wright, KY 41011 Phone: 859-750-5642 Fax: 859-331-1742 |
News Archive
The age a woman begins menstruation is associated with having high blood pressure later in her life, according to a team of researchers at the University of Georgia.
While Washington, D.C. couldn't seem further away to most Idaho families this holiday season, rising health care costs are an issue that's hitting much closer to home. As Idaho's health care woes grow increasingly worse, AARP is calling on Senators Mike Crapo and Jim Risch to vote in favor of the Senate health care reform bill expected to come up for a vote Christmas Eve, and is sending the Senators a "Christmas List" of Idaho's health care crisis.
A Toll-like receptor (TLR) agonist, called imiquimod, which activates dendritic cells, is in clinical use as a topical application for basal cell carcinoma. In addition, a number of TLR agonists have been evaluated in clinical trials as an adjuvant for cancer vaccines.
The Government of Rwanda, together with QIAGEN N.V. and Merck, known as MSD outside the United States and Canada, today announced the launch, in Kigali, Rwanda, of a comprehensive national cervical cancer prevention program that includes vaccination with GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] for appropriate girls 12 to 15 years of age and modern molecular diagnostic screening for women between the ages of 35 and 45.
The Government of the Republic of Equatorial Guinea announced an agreement with industry partners, Marathon Oil Corporation, Noble Energy Inc. and AMPCO, to sponsor the clinical development of Sanaria PfSPZ Vaccine against malaria, including a series of clinical trials from 2015 until 2018.
› Verified 7 days ago